Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether patient self-report of severe hypoglycemia is associated with increased mortality. RESEARCH DESIGN AND METHODS: Adult patients (N = 1,020) seen in a specialty diabetes clinic between August 2005 and July 2006 were questioned about frequency of hypoglycemia during a preencounter interview; 7 were lost to follow-up and excluded from analysis. Mild hypoglycemia was defined as symptoms managed without assistance, and severe hypoglycemia was defined as symptoms requiring external assistance. Mortality data, demographics, clinical characteristics, and Charlson comorbidity index (CCI) were obtained from the electronic medical record after 5 years. Patients were stratified by self-report of hypoglycemia at baseline, demographics were compared using the two-sample t test, and risk of death was expressed as odds ratio (95% CI). Associations were controlled for age, sex, diabetes type and duration, CCI, HbA1c, and report of severe hypoglycemia. RESULTS: In total, 1,013 patients with type 1 (21.3%) and type 2 (78.7%) diabetes were questioned about hypoglycemia. Among these, 625 (61.7%) reported any hypoglycemia, and 76 (7.5%) reported severe hypoglycemia. After 5 years, patients who reported severe hypoglycemia had 3.4-fold higher mortality (95% CI 1.5–7.4; P = 0.005) compared with those who reported mild/no hypoglycemia. CONCLUSIONS: Self-report of severe hypoglycemia is associated with 3.4-fold increased risk of death. Patient-reported outcomes, including patient-reported hypoglycemia, may therefore augment risk stratification and disease management of patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The primary cause of hypoglycemia is intensification of antihyperglycemic therapy (almost always using SUs [or to a lesser extent glinides] and/or insulin) aimed at achieving lower A1C targets, as demonstrated by intensive therapy trials.1202,1203”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1202]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“multiple studies have shown a strong relationship between hypoglycemia (severe or not severe) and cardiovascular events and mortality”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [195]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An association between selfreported level 3 hypoglycemia and 5-year mortality has also been reported in clinical practice (91).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [91]
The cited source says what the claim attributes to it.
In the citing paper
“An association of level 3 hypoglycemia with mortality was also found in the ADVANCE trial and in clinical practice (77,78).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · cited 1×
“The CCI is an extensively studied and widely used measure that weighs comorbid conditions by the strength of their association with 1-year mortality (17,18); it has been previously validated for use in diabetes (19).”
BackgroundIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Cited by
Items 201–300 of 541
Conceição, J., Dores, J. M., Araújo, F., Laires, P. A., Carr, R. D., Brodovicz, K. G., Radican, L., & Nogueira, A. M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13030 · Cited by 25
“4-fold increase in 5-year mortality.(5) Hypoglycaemia is also associated with a significant economic burden.”
BackgroundApproaches to risk assessment among older patients with diabetes
Pilla, S. J., Schoenborn, N. L., Maruthur, N. M., & Huang, E. S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1172-z · Cited by 24
Hypoglycemia communication in primary care visits for patients with diabetes
Pilla, S. J., Park, J., Schwartz, J. L., Albert, M. C., Ephraim, P. L., Boulware, L. E., Mathioudakis, N. N., Maruthur, N. M., Beach, M. C., & Greer, R. C. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06385-x · Cited by 23
Funamizu, T., Iwata, H., Nishida, Y., Miyosawa, K., Doi, S., Chikata, Y., Shitara, J., Endo, H., Wada, H., Naito, R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00996-8 · Cited by 27
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Escalada, J., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.005 · Cited by 29
Nordwall, M., Fredriksson, M. G., Ludvigsson, J., & Arnqvist, H. J. (2019) · Diabetes Care · doi:10.2337/dc18-1950 · Cited by 24
“requires a very tight glycemic control, which is very difficult to achieve with the treatment tools available today and is also dangerous because of the risk of severe hypoglycemia (27).”
BackgroundLeFevre, J., Cyriac, S. L., Tokmic, A., & Pitlick, J. M. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac244 · Cited by 24
Li, G., Zhong, S., Wang, X., & Zhuge, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1222409 · Cited by 26
“The mechanisms that relate SH to non-cardiovascular fatalities remain unknown (22, 54).”
BackgroundHypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes
Biagetti, B. (2013) · World Journal of Clinical Cases · doi:10.12998/wjcc.v1.i5.169 · Cited by 22
Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus
Guglielmi, C., Williams, S. R., Toro, R. D., & Pozzilli, P. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1180363 · Cited by 22
“The subcutaneous administration of insulin also creates the potential for the induction of hypoglycemia, which in itself is associated with increased mortality compared to T1DM patients, who do not experience hypoglycemia.[7] Prospective studies [8] have demonstrated that T1DM patients who retain even a modest degree…”
BackgroundBiomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD
Chow, L. S., Chen, H., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetologia · doi:10.1007/s00125-015-3512-0 · Cited by 25
“Of particular importance are recent findings demonstrating an association between SH and insulin use [3–5], even in patients who do not achieve intensive glucose targets [6, 7, 20].”
BackgroundSevere Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes
Mahoney, G. K., Henk, H. J., & McCoy, R. G. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.02.028 · Cited by 26
Self-citationAdverse safety events in patients with Chronic Kidney Disease (CKD)
Offurum, A. I., Wagner, L.-A., & Gooden, T. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1236909 · Cited by 23
Personal Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older
Argento, N. B., & Nakamura, K. (2014) · Endocrine Practice · doi:10.4158/ep14017.or · Cited by 23
McCoy, R. G., Herrin, J., Galindo, R. J., Sindhu Swarna, K., Umpierrez, G. E., Hill Golden, S., & O'Connor, P. J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110263 · Cited by 20
Self-citationMeng, G., Gu, J., Liew, S. Y., Cao, J., Wang, Z., Ma, C., Fu, Z., Zhou, H., Wang, J., Wang, S., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.07.006 · Cited by 23
Newswanger, B., Prestrelski, S. J., & Andre, A. D. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1653278 · Cited by 20
“4-fold higher among those with severe hypoglycemia compared to those with no or mild hypoglycemia [4].”
BackgroundDejager, S., Detournay, B., Halimi, S., Robert, J., & Deschaseaux, C. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s84507 · Cited by 20
The Current State of Pancreas Transplantation in the USA—A Registry Report
Gruessner, A. C., & Gruessner, R. W. G. (2018) · Current Transplantation Reports · doi:10.1007/s40472-018-0213-x · Cited by 20
Flatt, A. J., Chen, E., Peleckis, A. J., DALTON-BAKES, C. V., Nguyen, H.-L., Collins, H. W., Millar, J. S., Gallop, R., & Rickels, M. R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0103 · Cited by 23
Anderson, T. S., Lee, A. K., Jing, B., Lee, S., Herzig, S. J., Boscardin, W. J., Fung, K. Z., Rizzo, A., & Steinman, M. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.28998 · Cited by 20
Hougen, I., Whitlock, R. H., Komenda, P. V. J., Rigatto, C., Clemens, K. K., & Tangri, N. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002352 · Cited by 23
Xu, X., Ran, Y., Huang, C., & Yin, Z. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00016 · Cited by 19
Kim, K. M., Park, K. S., Lee, H. J., Lee, Y. H., Bae, J. S., Lee, Y. J., Choi, S. H., Jang, H. C., & Lim, S. K. (2015) · Scientific Reports · doi:10.1038/srep18214 · Cited by 21
Lablanche, S., David‐Tchouda, S., Margier, J., Schir, É., Wojtusciszyn, A., Borot, S., Kessler, L., Morélon, E., Thivolet, C. H., Pattou, F. N., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013434 · Cited by 23
Burne, R. M., & Abrahamowicz, M. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280217726800 · Cited by 22
Lysy, Z., Fung, K., Giannakeas, V., Fischer, H. D., Bell, C. M., & Lipscombe, L. L. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-04849-3 · Cited by 19
Toida, T., Sato, Y., Ogata, S., Wada, A., Masakane, I., & Fujimoto, S. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.09.007 · Cited by 20
Farrell, C. M., McNeilly, A. D., Fournier, P. A., Jones, T. W., Hapca, S. M., West, D. J., & McCrimmon, R. J. (2020) · Diabetologia · doi:10.1007/s00125-019-05076-5 · Cited by 24
“Severe hypoglycaemia is an adverse effect of insulin therapy in diabetes that has a well-recognisedmorbidity andmortality [1].”
BackgroundBiester, T., Schwandt, A., Heidtmann, B., Rami-Merhar, B. M., Haak, T., Festa, A., Kostow, S., Müller, A., Mönkemöller, K., Danne, T., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0675 · Cited by 21
Insulin use in chronic kidney disease and the risk of hypoglycemic events
Grube, D., Wei, G., Boucher, R. E., Abraham, N., Zhou, N., Gonce, V., Carle, J., Simmons, D. L., & Beddhu, S. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02687-w · Cited by 21
Sejling, A., Schouwenberg, B., Færch, L., Thorsteinsson, B., de Galan, B. E., & Pedersen‐Bjergaard, U. (2015) · Diabetic Medicine · doi:10.1111/dme.12810 · Cited by 24
Hypoglycemia and diabetes: increased need for awareness
Shaefer, C. F., Hinnen, D., & Sadler, C. E. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1163255 · Cited by 22
Pathophysiology and management of hypoglycemia in diabetes
RANGEL, E. S., Deajon-Jackson, J. D., & Hwang, J. J. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14904 · Cited by 21
Burden of impaired awareness of hypoglycemia in people with diabetes undergoing hemodialysis
Habte‐Asres, H. H., Jiang, Y., Rosenthal, M. J., & Wheeler, D. C. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003730 · Cited by 18
Doucet, J., Bauduceau, B., Floch, J. P. L., Verny, C., & Intergroup, T. S. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12160 · Cited by 19
García-Caballero, M., Martínez-Moreno, J. M., Toval, J. A., Miralles, F., Mínguez, A., Osorio, D., Mata, J. M., & Reyes-Ortiz, A. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6712 · Cited by 20
“4-fold increased risk of death.(5) Morbidity and mortality in type 1 diabetic patients derive mainly from advanced microvascular, neuropathic, and macrovascular complications, with the major clinical impact beginning 15-20 years after the onset of diabetes.”
BackgroundRodríguez‐Gutiérrez, R., Lipska, K. J., & McCoy, R. G. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8320 · Cited by 18
Self-citationFelix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 19
Nimri, R., Yakoob, H., Schoenberg, B. E., & Dassau, E. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.2504 · Cited by 20
Mezquita‐Raya, P., Reyes‐García, R., Moreno, Ó., Muñoz‐Torres, M., Merino-Torres, J. F., Martínez, J. J. G., Jódar-Gimeno, E., Martín, J. E. S., Gargallo-Fernández, M., Soto-González, A., et al. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.11.009 · Cited by 27
Jeon, J. Y., Kim, S. R., Kim, H. J., Kim, D. J., Lee, K. W., Lee, J.-D., & Han, S. J. (2016) · Medicine · doi:10.1097/md.0000000000005365 · Cited by 22
“Keywords: diabetes, emergency department, neurological sequelae, self-monitoring of blood glucose, severe hypoglycemia [1,2]”
BackgroundAssociation between hypoglycemia risk and hemoglobin A1C in patients with type 2 diabetes mellitus
Yu, S., Fu, A. Z., Engel, S. S., Shankar, R. R., & Radican, L. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1176017 · Cited by 25
Jiang, D. H., Herrin, J., Van Houten, H. K., & McCoy, R. G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50602 · Cited by 17
Self-citationMisra‐Hebert, A. D., Ji, X., Pantalone, K. M., Hu, B., Dey, T., Milinovich, A., Bauman, J. M., Zimmerman, R. S., & Kattan, M. W. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107490 · Cited by 18
Continuous Glucose Monitoring as a Matter of Justice
Kraaijeveld, S. R. (2020) · HEC Forum · doi:10.1007/s10730-020-09413-9 · Cited by 19
Access to emergency room for hypoglycaemia in people with diabetes
Salutini, E., Bianchi, C., Santini, M., Dardano, A., Daniele, G., Penno, G., Miccoli, R., & Prato, S. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2667 · Cited by 18
Hypoglycaemia, thrombosis and vascular events in diabetes
King, R., & Ajjan, R. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1215916 · Cited by 17
Pilla, S. J., Kraschnewski, J. L., Lehman, E. B., Kong, L., Francis, E., Poger, J. M., Bryce, C. L., Maruthur, N. M., & Yeh, H.-C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002153 · Cited by 16
Stantonyonge, N., Sampedro, F., Méndez, J., Martínez‐Horta, S., Chico, A. I., & Gómez‐Ansón, B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa832 · Cited by 16
Hypoglykämie und Herzrhythmusstörungen bei Patienten mit Diabetes Typ 2
Hanefeld, M., Ganz, X., & Nolte, C. (2014) · Herz · doi:10.1007/s00059-014-4086-1 · Cited by 18
Emons, M. F., Bae, J. P., Hoogwerf, B. J., Kindermann, S. L., Taylor, R., & Nathanson, B. H. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000160 · Cited by 20
Goh, S., Hussein, Z. B., & Rudijanto, A. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12647 · Cited by 20
Jeon, J. Y., Ha, K. H., & Kim, D. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0057 · Cited by 20
“In particular, severe hypoglycemia is strongly associated with higher mortality and cardiovascular disease [22,23].”
BackgroundHeller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14208 · Cited by 17
Moser, O., Rafferty, J., Eckstein, M. L., Aziz, F., Bain, S. C., Bergenstal, R. M., Sourij, H., & Thomas, R. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15102 · Cited by 17
“4 times greater than those who had not had prior hypoglycaemia.(24) Clinical characteristics associated with an increased risk of all-cause mortality were pre-existing macrovascular disease and reduced kidney function; however, the sample size was small, with only 59 deaths in 751 people.”
BackgroundA metabolomic signature of decelerated physiological aging in human plasma
Janssens, G. E., Grevendonk, L., Schomakers, B. V., Perez, R. Z., van Weeghel, M., Schrauwen, P., Hoeks, J., & Houtkooper, R. H. (2023) · GeroScience · doi:10.1007/s11357-023-00827-0 · Cited by 16
“Since these are chronic conditions with potentially increased mortality rates [27, 28], the physiAge score would not be the most relevant Fig.”
BackgroundDiabetes Management Experience and the State of Hypoglycemia: National Online Survey Study
Zahed, K., Sasangohar, F., Mehta, R. K., Erraguntla, M., & Qaraqe, K. A. (2020) · JMIR Diabetes · doi:10.2196/17890 · Cited by 16
“When the body is unable to secrete epinephrine that generates hypoglycemic symptoms [8], the risk of death could increase by more than 3-fold [9].”
Porcellati, F., Mauro, S. D., Mazzieri, A., Scamporrino, A., Filippello, A., Fano, M. D., Fanelli, C. G., Purrello, F., Malaguarnera, R., & Piro, S. (2021) · Biomolecules · doi:10.3390/biom11091281 · Cited by 19
“It can increase the risk of cardiovascular events [33,34], dementia [35], fractures [36], and overall mortality [37].”
BackgroundThe Giant Geriatric Syndromes Are Intensified by Diabetic Complications
Lewandowicz, A., Skowronek, P., Maksymiuk-Kłos, A., & Piątkiewicz, P. (2018) · Gerontology and Geriatric Medicine · doi:10.1177/2333721418817396 · Cited by 21
“This is more common in type 1 diabetes, although their occurrence in type 2 diabetes is also serious (McCoy et al., 2012).”
BackgroundPöhlmann, J., Mitchell, B. D., Bajpai, S., Osumili, B., & Valentine, W. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819826577 · Cited by 16
Choi, S.-Y., & Ko, S. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.327 · Cited by 18
“SH is a strong predictor of major CV events and mortality in patients with T2DM [13-16], although it is unclear whether this is due to a direct pathophysiological association or whether SH acts as a marker of vulnerability to CV events.”
BackgroundShiau, C.-H., Tsau, L.-Y., Kao, C., Peng, Y., Bai, C., Wu, J., & Hou, W. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03789-6 · Cited by 14
“Hypoglycemia is a common side effect of SGLT2i and increases the risk of mortality [84].”
Cahn, A., Raz, I., Mosenzon, O., Leibowitz, G., Yanuv, I., Rozenberg, A., Iqbal, N., Hirshberg, B., Sjöstrand, M., Stahre, C., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2763 · Cited by 16
Luk, A. O. Y., Ho, T. S. T., Lau, E. S. H., Ko, G. T. C., Ozaki, R., Tsang, C.-C., Kong, A. P. S., Ronald, C. W., So, W., Chow, F. C. C., et al. (2016) · Medicine · doi:10.1097/md.0000000000005183 · Cited by 18
Endoplasmic reticulum stress: A common pharmacologic target of cardioprotective drugs
Mooradian, A. D., & Haas, M. J. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175221 · Cited by 14
New risk and protective factors for severe hypoglycaemia in people with type 1 diabetes
Wohland, T., Holstein, J. D., Patzer, O. M., Mende, M., Tiemann, T., Koch-Tessarek, C., Kovacs, P. L., & Holstein, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.12.006 · Cited by 15
Antecedent Hypoglycemia Does Not Attenuate the Acceleration of Gastric Emptying by Hypoglycemia
Kar, P., Jones, K. L., Plummer, M. P., Abdelhamid, Y. A., Giersch, E. J., Summers, M. J., Hatzinikolas, S., Heller, S. R., Horowitz, M., & Deane, A. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00051 · Cited by 14
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
Heller, S. R., Lingvay, I., Marso, S. P., Philis‐Tsimikas, A., Pieber, T. R., Poulter, N. R., Pratley, R. E., HACHMANN-NIELSEN, E., Kvist, K., Lange, M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14049 · Cited by 15
Saik, O., & Klimontov, V. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212419 · Cited by 19
“In both type 1 and type 2 diabetes, self-reported episodes of severe hypoglycemia are related to increased risk of death [3].”
BackgroundHoffman, E. G., D’Souza, N. C., Liggins, R. T., & Riddell, M. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1295639 · Cited by 13
Tyagi, P., Koskinen, M., Mikkola, J. H., Sarkhel, S., Leino, L., Seth, A., Madalli, S., Will, S., HOWARD, V. G., Brant, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030553 · Cited by 14
“Excessive moderation of glucose levels might result in hypoglycemic conditions and may prove fatal [18].”
BackgroundHtoo, P. T., Paik, J. M., Alt, E. M., Kim, D. H., Wexler, D. J., Kim, S. C., & Patorno, E. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad075 · Cited by 14
Diallo, A. M., Novella, J., Lukas, C., Souchon, P., Dramé, M., François, M., Decoudier, B., Barraud, S., Salmon-Musial, A. S., Ancelle, D., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.011 · Cited by 17
Kaewput, W., Thongprayoon, C., Rangsin, R., Bathini, T. J., Torres‐Ortiz, A., Mao, M. A., & Cheungpasitporn, W. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1792921 · Cited by 15
Nuzzo, A., Brignoli, A., Ponziani, M. C., Zavattaro, M., Prodam, F., Castello, L. M., Avanzi, G. C., Marzullo, P., & Aimaretti, G. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.016 · Cited by 14
Preparation of multiresponsive nanogels and their controlled release properties
Yuan, S., Li, X., Shi, X., & Lu, X. (2019) · Colloid & Polymer Science · doi:10.1007/s00396-019-04481-x · Cited by 13
Assessing Prevalence of Hypoglycemia in a Medical Transcription Database
Uzoigwe, C., Hamersky, C. M., Arbit, D. I., Weng, W., & Radin, M. S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s235298 · Cited by 14
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies
Pistrosch, F., & Hanefeld, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0678-2 · Cited by 14
High concurrent use of sulfonylureas and antimicrobials with drug interactions causing hypoglycemia
Pilla, S. J., Pitts, S. I., & Maruthur, N. M. (2022) · Journal of Patient Safety · doi:10.1097/pts.0000000000000739 · Cited by 12
Kang, S. Y., Park, Y., Kwon, D. J., Chung, Y., Namkung, J., Han, K., & Ko, S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0135 · Cited by 15
“Although the incidence rate of SH is low in T2DM [7], its occurrence can be fatal due to the risk of loss of consciousness, falls, seizures, motor vehicle accidents, coma, and death [8].”
BackgroundZhang, J., Wu, J. W., Shi, X., Li, D., Yang, S., Zhang, R., Xia, B., & Yang, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300283 · Cited by 13
Guevara, E., Simó-Servat, A., Perea, V., Quirós, C., Puig-Jové, C., Formiga, F., & Barahona, M. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175325 · Cited by 14
“…effects of hypoglycemia in older individuals are well-documented [111], contributing to an increased risk of cardiovascular events [112], cardiac arrhythmias, ischemic stroke, delirium [113], hospitalization [114], and mortality [112,115], with significant economic and social impact [116].”
BackgroundAğraz, M., Deng, Y., Karniadakis, G. E., & Mantzoros, C. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-69844-z · Cited by 18
Hong, S., Presswala, L. S., Harris, Y., Romao, I., Ross, D. W., Andrade, H. P., Zhang, M., Jhaveri, K. D., Sakhiya, V., & Fishbane, S. N. (2020) · Kidney360 · doi:10.34067/kid.0001272020 · Cited by 12
“Hypoglycemia also increases anxiety among patients and may hinder the ability to achieve optimal chronic glucose control, as well as increasing the risk of mortality (13,14).”
BackgroundPotential Risk of Hypoglycemia in Patients with Heart Failure
Teshima, Y., Shiga, R., Saito, S., Kondo, H., Fukui, A., Fukuda, T., Okada, N., Akioka, H., Shinohara, T., Akiyoshi, K., et al. (2020) · International Heart Journal · doi:10.1536/ihj.20-134 · Cited by 13
Hypoglycaemia Among Diabetes Patients: A Preventive Approach
Mohajan, D., & Mohajan, H. K. (2023) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2023.09.05 · Cited by 12
Rauh, S. P., Rutters, F., Thorsted, B. L., Wolden, M. L., Nijpels, G., van der Heijden, A. A. W. A., Walraven, I., Elders, P. J. M., Heymans, M. W., & Dekker, J. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012793 · Cited by 14
“While we studied patient-reported hypoglycaemic sensations rather than objectively measured events only, we showed that self-reported hypoglycaemic sensations are highly prevalent in the insulintreated T2D population, and that self-reported hypoglycaemic sensations not requiring medical assistance are not associated w…”
ResultInfluentialGraduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study
O’Donnell, H. K., Berget, C., Wooldridge, J. S., & Driscoll, K. A. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12791 · Cited by 17
“Hypoglycemia is one of the most common and potentially dangerous acute complications of type 1 diabetes (T1D).(1) Many individuals perceive the occurrence of hypoglycemia to be unpredictable and uncontrollable and as a result, its symptoms and potential for immediate life-threatening complications can cause significan…”
BackgroundDalbhi, S. A., ALEissa, M., ALGHOFAILI, I. A., Alotaibi, H. F., Yaslam, M., AlMujil, M., & Arnous, M. M. (2020) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_304_19 · Cited by 13
“MetaXL was used to calculate the pooled incidence of hypoglycemia in patients with CKD. Risk ratio or incidence ratio along with 95% confidence interval (CI) of hypoglycemia in patients with CKD and without CKD was used as a summary measure for effect to compare the incidence between these two groups.”
BackgroundInfluentialCost and co-morbidities associated with hypoglycemic inpatients in Belgium
Chevalier, P., Vandebrouck, T., Keyzer, D. D., Mertens, A. C., & Lamotte, M. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1086775 · Cited by 17
On Ensuring that Intelligent Machines Are Well-BehavedPreprint
Thomas, P. S., da Silva, B. C., Barto, A. G., & Brunskill, E. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1708.05448 · Cited by 16
Benning, T. J., Heien, H. C., Herges, J. R., Creo, A. L., Al Nofal, A., & McCoy, R. G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111026 · Cited by 11
Self-citationHypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality
González‐Vidal, T., Lambert, C., García, A. V., Villa-Fernández, E., Pujante, P., Ares, J., Torre, E. L. M., & Delgado, E. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01329-5 · Cited by 12
“Of note, the relative risk (hazard ratio) of mortality associated with hypoglycemia in these studies was between 2-and threefold [35, 36, 38], similar to that observed in the present study.”
BackgroundResultMyers, L. A., Swanson, K. M., Glasgow, A. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1811 · Cited by 16
Self-citationHypoglycemia unawareness prevention: Targeting glucagon production
Samson, W. K., Stein, L. M., Elrick, M. M., Salvatori, A. S., Kolar, G. R., Corbett, J. A., & Yosten, G. L. C. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.04.012 · Cited by 11
Naik, S., Belfort‐DeAguiar, R., Sejling, A., Szepietowska, B., & Sherwin, R. S. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12855 · Cited by 11
“Indeed, severe hypoglycaemia is a significant cause of morbidity, as well as mortality, in T1DM patients.(5,6) Thus, there is an urgent need to develop new safe strategies for prevention and treatment of hypoglycaemia unawareness.”
BackgroundReevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
Lamprea-Montealegre, J. A., & de Boer, I. H. (2018) · Diabetes Care · doi:10.2337/dci17-0063 · Cited by 11
Hariyanto, T. I., Lugito, N. P. H., Yanto, T. A., Siregar, J. I., & Kurniawan, A. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210709164925 · Cited by 11
Schroeder, E. B., Neugebauer, R. S., Reynolds, K., Schmittdiel, J. A., Loes, L., Dyer, W., Pimentel, N., DESAI, J. R., Vazquez‐Benitez, G., Ho, P. M., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.26605 · Cited by 11
Metadata
- Authors
- McCoy, R. G., Van Houten, H. K., Ziegenfuss, J. Y., Shah, N. D., Wermers, R. A., & Smith, S. A.
- Affiliations
- Mayo Clinic (US)
- Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
- Corresponding author
- Smith, Steven A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1897-1901
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425008
- OpenAlex
- W2153957843
- Semantic Scholar
- 28fffca9598fb24277bf9ea60849e4ad6060f499
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 34 · 2023: 37 · 2022: 46 · 2021: 35 · 2020: 46 · 2019: 59 · 2018: 36 · 2017: 43 · 2016: 50 · 2015: 49 · 2014: 39 · 2013: 24 · 2012: 3
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, diabetes mortality, patient self-report, patient-reported outcomes, type 1 diabetes, type 2 diabetes, risk stratification, Charlson Comorbidity Index, HbA1c, diabetes complications
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Male, Retrospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.